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Initiation of adaptive immunity involves distinct migratory cell populations coming together
in a highly dynamic and spatially organized process. However, we lack a detailed
spatiotemporal map of these events due to our inability to track the fate of cells between
anatomically distinct locations or functionally identify cell populations as migratory. We
used photo-convertible transgenic mice (Kaede) to spatiotemporally track the fate and
composition of the cell populations that leave the site of priming and enter the draining
lymph node to initiate immunity. We show that following skin priming, the lymph node
migratory population is principally composed of cells recruited to the site of priming,
with a minor contribution from tissue resident cells. In combination with the YAe/Eα
system, we also show that the majority of cells presenting antigen are CD103+CD11b+
dendritic cells that were recruited to the site of priming during the inflammatory response.
This population has previously only been described in relation to mucosal tissues.
Comprehensive phenotypic profiling of the cells migrating from the skin to the draining
lymph node by mass cytometry revealed that in addition to dendritic cells, the migratory
population also included CD4+ and CD8+ T cells, B cells, and neutrophils. Taking our
complex spatiotemporal data set, we then generated a model of cell migration that
quantifies and describes the dynamics of arrival, departure, and residence times of cells
at the site of priming and in the draining lymph node throughout the time-course of the
initiation of adaptive immunity. In addition, we have identified the mean migration time
of migratory dendritic cells as they travel from the site of priming to the draining lymph
node. These findings represent an unprecedented, detailed and quantitative map of cell
dynamics and phenotypes during immunization, identifying where, when and which cells
to target for immunomodulation in autoimmunity and vaccination strategies.
Keywords: cell migration, dendritic cells, adaptive immunity, innate immunity, cell tracking
INTRODUCTION
Initiation of adaptive immunity involves a number of migratory and tissue resident cell populations
coming together in a highly dynamic and spatially organized process. A detailed understanding
of the spatiotemporal organization of this process is a significant goal in basic immunology.
Furthermore, this information would also allow the rational development of new therapeutics
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and immune modulators, ensuring the correct cells are targeted
at the correct location and time to optimize efficacy while
minimizing off target effects. However, we currently lack a
definitive description of the spatiotemporal organization of
immune cell migration leading up to initiation of adaptive
immunity. This is mainly due to our inability to faithfully
track cells between spatially distinct locations or definitively
identify these migratory cell populations. Current approaches
to study cell migration include for example, transfer of
exogenously labeled cells (1–3), injection of labeled dyes or
analysis of cell markers associated with migration. However,
these approaches suffer from issues of physiological relevance,
fidelity to pharmacodynamics and distribution and a lack of
functional link to cell migration as well as having a bias toward
cell populations known to express that marker, respectively. An
ideal cell tracking, or fate-mapping approach should therefore
address these issues.
The Kaedemouse ubiquitously expresses the photo-switchable
fluorescent protein Kaede that undergoes a beta elimination
reaction following exposure to violet light resulting in a shift in
excitation and emission (4, 5). Photoswitching is easily identified
in the emission shift from green (518 nm) to red wavelengths
(582 nm) using conventional flow cytometry or fluorescence
microscopy. The Kaede system therefore offers the unique
potential to track all of the cell populations originating from a
site of light exposure within the whole-organism. This approach
therefore labels cells in situ, addressing issues of physiological
relevance associated with cell transfer and pharmacokinetic
issues associated with administration of fluorescent dyes such as
FITC (6, 7). Furthermore, because all of the cells in a tissue are
labeled, this does not require prior knowledge of the migratory
cells of interest, overcoming a biased approach to studying cell
migration. Due to the advantages of Kaede mice over these
methods, they provide an excellent tool to further our current
understanding of cell migration.
In this study, we apply the Kaede transgenic mouse model,
to produce a definitive, spatially and temporally resolved
map of cell migration between the site of immunization and
the draining lymph node during initiation of an adaptive
immune response. We use the unbiased and functional
identification of migratory cells offered by this system, to perform
comprehensive phenotypic identification of cells using mass
cytometry. Significantly, we show that contrary to current dogma,
the majority of cells migrating from the site of immunization
to the draining lymph node (dLN) are not tissue resident,
however are recruited into the tissue following immunization
with defined kinetics. Thus, we have defined in unprecedented
detail, when, where and what cells are involved in initiation of an
adaptive immune response, generating a fundamental reference
source, and importantly informing the rational targeting of
immunotherapy in vivo.
MATERIALS AND METHODS
Mouse Strains
C57BL/6 mice were purchased from Envigo at 6 weeks of
age. The Kaede transgenic mouse colony was kindly provided
by Tomura (5). All animals were maintained under standard
conditions at the University of Glasgow Central Research Facility
and all procedures were carried out according to UK Home
Office regulations.
Photo-Conversion of Kaede Mouse Tissue
Photo-conversion of the Kaede mouse tissue was performed
using a 12x S06J bluray diode with a 405-G-2-glass lens (DTR’s
Laser Shop) emitting at 405 nm with mean power of 600–650
mW. Post-immunization, mice were anesthetized and the ventral
and dorsal side of the hind paw were illuminated with the laser
for three 5 s bursts, with a 3 s interval between each burst, as
previously optimized (data not shown). Photo-conversion was
only performed once per animal.
Immunization, Adjuvants, and Antigen
Mice were subcutaneously injected with 25 µl of 5 mg/ml
aluminum hydroxide gel adjuvant (alum) (A kind gift from
Dr. Erik Lindblad, Brenntag Biosector, Denmark) solution
containing 8 µg of E. coli lipopolysaccharide (LPS) (serotype:
055:B5; Sigma Aldrich, UK) in the hind footpad, under isoflurane
induced general anesthesia. 50µg of an Eα peptide (I-Eα 52–68 of
I-Ed)—Ovalbumin conjugate (Eα:OVA) (ALMAC, Scotland) was
also injected subcutaneously to track antigen presentation using
the Y-Ae monoclonal antibody (8, 9).
Flow Cytometry
Skin was removed from the hind paw, minced and digested in
100 U/ml of DNAse, 2mg/ml of collagenase IV from Clostridium
hisolyticum and 2 mg/ml of hyaluronidase from bovine testes
(Sigma Aldrich). The remainder of the paw was teased apart
with tweezers and added to the digestion mix. Samples were
incubated for 20min at 37◦C in a shaking incubator. Following
digestion, samples were passed through 100µm cell strainers.
The popliteal lymph nodes were gently passed through a nitex
mesh (Cadisch Precision Meshes) using the rubber end of a 1ml
syringe plunger and digested in 2.68 mg/mL of collagenase D
from Clostridium hisolyticum (Roche) for 25min at 37◦C in a
shanking incubator. 100 µl of 100 µM EDTA was added to each
sample to halt the reaction (10). Prior to staining 10 µl of each
sample was removed and used to enumerate the total number
of cells per sample using a hemocytometer, dead cell exclusion
was performed with trypan blue. Samples were passed through a
nitex mesh for a second time to generate a single cell suspension
and incubated in 50 µl of Fc block [2.4G2 grown in-house
(9)] containing 5% mouse serum for 10min and subsequently
stained with combinations of the following antibodies for 20–30
min: anti-CD11b (M1/70), anti-CD11c (HL3), anti-CD45 (30-7-
11), anti-MHCII (M5/114.15.2), anti-Ly6G (IA-8), biotinylated
YAe (eBio-YAe) (all eBioscience, Hartfield, UK), and anti-CD103
(2E7) (BD Biosciences). Detection of biotinylated YAe was
performed using Streptavidin APC-eFluor R©780 (eBioscience).
Cell viability wasmeasured using fixable eFluor R©780 viability dye
(eBioscience). Red and green Kaede were detected using the PE
and FITC channels, respectively. Data was acquired on a LSRII
flow cytometer running FACSDiva software (BD bioscience)
and subsequently analyzed using Flowjo software (Tree star,
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Inc., USA). Gating strategies for flow cytometry experiments are
detailed in Supplementary Figure 1.
Mass Cytometry
Prior to mass cytometry, fixable eFluor R©780 viability dye, Kaede
red, and Kaede green cells were sorted on an FACSAriaII cell
sorter running FACSDiva software. Sorted cells were collected in
50% FCS. For mass cytometry, samples were incubated with
the following antibodies for 2 h at 4◦C: anti-CD3e (145-
2C11), anti-CD4 (RM4-5), anti-CD8α (53-6.7), anti-CD11b
(M1/70), anti-CD11c (N418), anti-CD19 (6D5), anti-CD25
(3C7), anti-CD44 (IM7), anti-CD45 (30-F11), anti-CD62L
(MEL-14), anti-CD69 (H1.2F3), anti-CD86 (GL1), anti-CD103
(2E7) anti-CD127 (A7R34), anti-CD197 (4B12), anti-APC
(APC003), anti-B220 (RA3-6B2), anti-biotin (1D4-C5),
anti-CTLA-4 (UV10-4B9), anti-F4/80 (BM8), anti-Ly6G
(RB6-8C5), anti-MHCII (M5/114.15.2), anti-NK1.1 (PK136),
anti-TcRβ (H57-597), and YAe (eBioY-Ae) (Fluidigm, South
San Francisco). Cells were then stained with DNA intercalator
overnight at 4
◦
C before being re-suspended in 500µl of ultrapure
water for data acquisition on a CyTOF 2. Analysis was performed
using Flowjo software (Tree star, Inc.) and Cytobank software
(Cytobank, Inc.). The gating strategy used for mass cytometry is
detailed in Supplementary Figure 2.
Mathematical Modeling
We used an array of mathematical models to describe the
dynamics of DC migrating between a site of inflammation and
the dLN. We fitted each model simultaneously to the time
courses of cell numbers in the two sites, under the different
photoswitching strategies. This process characterized (i) the
dynamics of egress of DC from skin over the 72 h following
challenge, (ii) transit between skin and the dLN, and (iii) the
distribution of residence times of migratory DC within the dLN.
Themodels are described in detail in Supporting Information 1.
Model simulation and parameter estimation was performed in R,
using nls() and optim(), the latter employing the Nelder-Mead
algorithm. Model selection was performed using the Akaike
information criterion (AIC).
Statistical Analysis
Results are presented as individual values with the mean, or the
mean individually ± 1 standard deviation (SD). Groups were
compared using a one-way ANOVA or a two-way ANOVA.
All statistical analysis was performed using Prism software
(Graph pad software, Inc.). P ≤ 0.05 were considered to be
statistically significant.
RESULTS
Photo-Conversion of the Kaede Protein
Does Not Impact Cell Viability or
Activation Status
In order to assess the effect of the 405 nm laser diode on
the kaede protein and cell viability we exposed lymph
nodes from kaede mice to the laser for 2–30 s ex-vivo and
assessed kaede fluorescence and viability by flow cytometry.
The 405 nm laser diode could successfully induce photo-
conversion of Kaede lymph node cells within 2 s of exposure
(Supplementary Figures 3A,B without loss of cell viability
(Supplementary Figure 3B). In addition, photo-conversion
using the 405 nm laser diode did not induce changes in the
activation status of bone marrow-derived dendritic cells
(BMDCs) in vitro as assessed by expression of MHCII, CD80,
and CD86 (Supplementary Figures 3C–E), nor did exposure
alter the ability of BMDCs to upregulate activation markers
CD80, CD86, and CD40 in response to LPS stimulation
(Supplementary Figures 3C–E).
Lymph Node Migratory Cell Population Is
Almost Completely Comprised of
Inflammatory, Rather Than Skin
Resident Cells
To assess how alum/LPS altered cellular composition at the
site of injection, we challenged mice in the hind footpad with
alum/LPS or saline and assessed the number of DCs and
neutrophils at the injection site by flow cytometry. Injection
with alum/LPS produced no significant change in the number
of DCs (CD11c+MHCII+) or neutrophils (CD11b+Ly6G+) at
the injection site compared with saline treated animals after
2 h (Figures 1A,B). However, alum/LPS induced a significant
increase in both DC and neutrophil numbers 12 h after injection
which remained elevated at 24 h. 48 h post-injection the number
of DCs began to reduce, while the number of neutrophils
remained significantly increased. The inflammatory site therefore
creates a dynamic environment with changing cell numbers
and profiles, that could impact on the phenotype of the LN
migratory population.
To successfully track cell migration from the footpad to the
draining lymph node we used the kaede transgenic mouse.
The kaede mouse ubiquitously expresses the Kaede protein in
all cells. When the protein is exposed to violet light, there
is a change in fluorescence from green to red. By inducing
photo-conversion locally in the footpad, we can track the cells
present at the time of photo-conversion as they migrate to
more distal sites such as the dLN. This system allows us
to fate map migratory cells without relying on differentially
expressed markers such as CD103, the expression of which
can be dynamically regulated during an immune response
(11). Therefore, we challenged Kaede mice with alum/LPS or
saline in the hind footpad, and photo-converted the injection
site 0, 4, 8, 12, or 24 h post-injection. Any cells expressing
red Kaede in the dLN must have originated at the site
of photo-conversion and will henceforth be referred to as
migratory cells The parameters used to identify migratory cells
are highlighted (Figure 1C). Delaying photo-conversion of the
footpad until 8 or 12 h post-challenge significantly increases
the percentage of migratory cells that can be identified in the
dLN (Figure 1D). This suggests that the majority of the LN
migratory cells during the inflammatory response to alum/LPS
are not tissue resident cells and must instead be recruited
to the site of challenge. We have also shown that upon
stimulation with alum alone, LPS alone or saline, the number
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FIGURE 1 | Inflammation at the site of injection drives migration to the draining lymph node. C57BL/6 mice were injected with alum/LPS in the left hind footpad and
saline in the right hind footpad and subsequently culled 0, 2, 12, 24, or 48 h later and the skin from the footpads analyzed by flow cytometry. (A) The total number of
live CD11c+MHCII+ cells isolated from the footpad and (B) the total number of live Ly6G+MHCII− cells isolated from the footpad are shown. n = 4 ± 1 SD
(**p < 0.01, ***p < 0.001). Kaede mice were injected with alum/LPS in the left hind footpad or saline in the right and the footpad was photo-converted at 0, 4, 8 or
12 h post injections. Mice were then culled 24 or 48 h after injection and the popliteal lymph node removed and analyzed by flow cytometry. (C) Migratory cells were
identified by gating out debris using FSC and SSC, doublet exclusion using FSC-A and FSC-H followed by identifying migratory cells based on Kaede red expression.
As we exposed the footpad to violet light only, any cells expressing Kaede red in the lymph node must have migrated there from the footpad. (D) The percentage of
migratory cells entering the draining lymph node directly from the footpad is shown. n = 3 ±1 SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). (E) the
number of inflammatory cells identified in the draining lymph node of Kaede mice after challenge with alum alone, LPS alone or alum/LPS over a 24 h period is shown.
n = 3 ± 1 SD (*p < 0.05).
of migratory cells in the dLN does not significantly change
24 h after injection. However, when we induce inflammation
using alum/LPS there is a significant increase in migratory
cell number within the dLN (Figure 1E). Each inflammatory
challenge is known to induce a large inflammatory response at
the site of challenge, however only the combination of alum/LPS
induced a significant increase in cell migration to the draining
lymph node. Furthermore, alum/LPS has a synergistic effect over
the individual components administered alone as the level of
migration observed with a combination approach is 4 times
greater than either individual treatment.
The Migratory Population Comprises
Multiple Populations, Including Antigen
Presenting CD103+CD11b+ DC
DCs are not the only cell type to migrate to the dLN upon
inflammatory challenge (12–14). Therefore, to maximize the
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FIGURE 2 | The migratory population contains diverse cell types, but the antigen presenting cells within this population are predominantly CD103+ CD11b+ dendritic
cells. Kaede mice were injected with Alum/LPS/Eα-OVA in the hind footpad, 12 h later the tissue was photo-converted and the animals were culled after a further 12 h.
(A) Analysis of the sorted, migratory population is shown with cells expressing MHCII represented in red, innate cells in blue and T cells in green. (B–D) The spade
diagrams show the levels of antigen presentation (YAe) detected on the lymph node resident population in untreated mice, mice treated with alum/LPS in the foot pad
and the migratory population of mice treated with alum/LPS in the footpad. Red and yellow nodes represent high and low expression of Eα:MHCII complexes,
respectively. (E) Dendritic cells were identified based on expression of CD11c and MHC class II. Representative dot plots identifying antigen presenting DCs and
(F) expression of CD44 and CD86 are shown. (G) The phenotype of DCs that expressed Eα:MHCII complexes and those that did not were further investigated based
on the expression of CD103 and CD11b. n = 3 ± 1 SD (****p < 0.0001).
number of cell lineages we could identify and reduce potential
bias from our data, we sorted the migratory population (red
Kaede) and subsequently analyzed it using multi-parameter mass
cytometry. Kaede mice were treated with alum/LPS containing
50 µg of Eα-OVA (alum/LPS/Eα) in the hind footpads. The
tissue was photo-converted 12 h later, and the mice culled after a
further 12 h. Of the migratory population, 45% expressed CD11c
and MHCII (DCs), 25% expressed CD3, TcRβ and CD4 (CD4T
cells), 5% expressed CD3, TcRβ and CD8 (CD8T cells), and
a small population of cells expressed CD3 but not TcRβ (γδ
T cells) (Figure 2). Another 5% of cells expressed CD11b and
Ly6G (neutrophils) and 10% express MHCII, CD19 and B220
(B cells). Finally, we identified a population of cells expressing
F4/80 (macrophages) and another expressing NK1.1 (NK cells)
(Figure 2A). Making use of the Eα/Y-Ae system we could also
show that only themigratory DCs had detectable levels of antigen
presentation (Figures 2B–D). The DCs identified as migratory
all had an activated phenotype (characterized by high expression
of CD44 and CD86) (Figures 2E,F). The markers CD103 and
CD11b are commonly used to define DC subsets in the skin,
gut and LN of mice (15–19). Interestingly, the majority of DCs
presenting Eα peptide on MHCII were CD103+CD11b+ and
while there was a migratory population that were CD103−, these
DCs did not present antigen (Figure 2G).
Most of the migratory CD4T cells expressed high levels
of CD44 and low levels of CD62L, indicative of an activated
phenotype (Supplementary Figure 4). Recent reports would
suggest that these are likely to be T effector memory or T
regulatory cells (14). The migratory B cell population could be
divided into the 3 main B cell subsets (B1a, B1b, and B2) based on
the expression of CD43 and CD5 (Figure 3A), all of these were
present within the migratory population (Figures 3B,C). These
data suggest that the migratory population is diverse with many
different cell types playing a role in the control of the adaptive
immune response. However, CD103+CD11b+ DCs constituted
the main antigen presenting population.
Migratory Cells Enter the Lymph Node
Within the First 24h and Migration From
the Inflammatory Site Persists for 48h
After Injection
To investigate how long migratory cells persisted in the dLN,
Kaede mice were challenged with alum/LPS in the hind footpad.
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FIGURE 3 | B1a, B1b, and B2 cells can be identified in the migratory population. Kaede mice were injected with alum/LPS or saline in the hind footpad and
photo-conversion was performed 12 h later. Mice were culled after a further 12 h and the popliteal lymph nodes analyzed by flow cytometry. (A) The gating strategy
used to identify B cells from the migratory population is highlight. Migratory cells were first identified and B cells selected based on B220 and CD19 expression. B cells
subsets were identified using CD5 and CD43. We show (B) The proportion and (C) numbers of each B cell subset. Data are representative of two independent
experiments. n = 3 ±1 SD.
The tissue was photo-converted 12 h later and the mice culled
24–72 h post-challenge to investigate time of arrival from the
skin and persistance in the dLN (Figures 4A,B). Migratory cells
could be detected in the lymph node 24 h after challenge with
the percentage of migratory cells decreasing significantly over
time and returning to the control levels by 72 h post injection
(Figure 4C). However, the number of migratory cells remains
constant between 24 and 36 h suggesting continuing migration
of cells that entered the inflammatory site after 12 h and were
therefore not photo-converted (Figure 4D).
To address the question of how long the inflammatory site
supplies cells to the dLN, mice were injected with alum/LPS and
photo-converted 12, 24, 36, or 60 h post injections and culled
12 h after photo-conversion (Figures 4E,F). The percentage of
migratory cells in the dLN was significantly increased when
mice were photo-converted 12 and 24 h post-injection with
a subsequent decrease when photo-conversion was performed
60 h post challenge. The number of migratory cells was also
significantly increased when photo-conversion was performed at
12, 24, and 36 h post-injection with a sharp decrease in migratory
cell number when photo-conversion was performed at 60 h post-
injection (Figures 4G,H). Based on these data we suggest that
cells are continually being recruited to the site of injection
before subsequently migrating to the dLN during the first 48 h
following injection.
Migratory Cells Present Antigen for 36h
Post Challenge
To investigate antigen presentation within the migratory
population, we combined the Y-Ae/Eα system with Kaede mice.
Representative flow cytometry plots of YAe staining control and
positive YAe staining highlight the effectiveness of the antibody
used to identify cells presenting antigen in the dLN (Figure 5A).
Photo-conversion 12 h after immunization revealed a significant
increase in the number of migratory cells presenting antigen in
the draining LN at 24, 36, and 48 h post-injection when compared
with control animals (Figure 5B). When we varied the time
of photo-conversion after immunization, but culled the mice
12 h later, we observed a significant increase in cells presenting
antigen in the dLN when compared with controls when mice
were photo-converted at 12 h post-challenge, with the number
of cells decreasing toward baseline thereafter (Figure 5C). This
kinetic data suggests that following injection with alum/LPS, the
majority of antigen presentation occurs on cells that arrive at the
site of injection during the first 36 h post-challenge and then take
at most, 12 h to migrate to the draining lymph node.
Modeling the Key Parameters Defining Cell
Migration to the Lymph Node
The data above highlight the limitations of describing
quantitative, dynamic data using descriptive terminology,
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FIGURE 4 | Cell migration from the site of challenge to the draining lymph node persists for 48 h post injection. (A,B) Footpads of mice were exposed to violet light
12 h after injection and were culled 24, 36, 48 or 72 h post injection. This strategy allowed us to quantify how long migratory cells took to travel to the dLN and how
(Continued)
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FIGURE 4 | long they persisted there. (C) The percentage and (D) the total number of live migratory cells in the draining lymph node are shown. (E,F) Alternatively, to
define how long migratory cells continue to leave the injection site, footpads were exposed to violet light at 12, 24, 36 of 60 h after injection and were culled 12 h after
the photo-conversion time. (G) The percentage and (H) the total number of live migratory cells in the draining lymph node are shown. n = 4 ± 1 SD (****p < 0.0001,
***p < 0.001, ** p<0.01 and *p<0.05; data are representative of two independent experiments).
FIGURE 5 | The peak of antigen presentation occurs at 24–36 h post challenge. Mice were treated with alum/LPS/Eα or saline/Eα, photoswitched 12 h later then flow
cytometry analysis of isolated LN was performed between 24 and 72 h post challenge. (A) The identification of YAe+ cells was performed using a YAe staining control
using the YAe antibody in samples without the Eα peptide. Positive staining in shown for comparison. (B) The number of live migratory MHCII+ cells that present
antigen (YAe+). Data are representative of two independent experiments. n = 4 ± 1 SD (**p < 0.01, ***p < 0.001). Mice were treated with alum and LPS or saline with
or without the Eα-OVA construct and culled between 24 and 72 h post challenge with photo-conversion performed 12 h before the cull. (C) The number of live
migratory MHCII+ cells that are presenting antigen (YAe+) is shown. n = 4 ±1 SD (**p < 0.01, ****p < 0.0001).
therefore we developed an array of simple mathematical models
to explain DC dynamics under steady state and inflammatory
conditions. We fitted the counts of photo-converted dendritic
cells to a set of models considering different assumptions for
the rates of migration and resident times in the draining lymph
nodes in alum/LPS treated and control animals (Figure 6A).
We found that the model describing constant rate of migration
under steady state conditions and time-dependent changes in
migration rate upon alum/LPS administration, was statistically
most favored (Figure 6B).
The best-fit model depicted in Figure 6B also shows that
DCs leaving an inflammatory environment survive longer and/or
egress the dLNmore slowly with t1/2 of 9.5 h in alum/LPS treated
mice and t1/2 of 3.8 h in control groups. Our simple model
considers that the transit times of DCs from the footpad to
popliteal lymph nodes is not affected by the inflammatory cues
in the footpad and was estimated to be 2.6 h for both treated
and control animals. Lastly, we found that the migration rate of
DCs in response to inflammatory conditions follows non-linear
dynamics, peaking around 26 h post alum/LPS administration
and is ∼10-fold higher than the basal migration rate at its
maximum value, implying that inflammation drives stronger
and sustained migration of DCs from skin tissue to lymph
nodes (Figure 7A). The mathematical model and experimental
data are summarized in Figures 7B–D highlighting the peak
of cell migration and antigen presentation in response to
inflammatory challenge.
DISCUSSION
Cell migration plays a critical role in initiating and controlling the
adaptive immune response (20–22). In this study, we have used
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FIGURE 6 | Modeling the trafficking of DC between skin and draining lymph nodes. (A) Schematic of the mathematical model of dendritic cell migration. Dendritic
cells in the foot pad (X) were photo-converted (X*) and migrate to the lymph node at the rate µ, taking a fixed transit time τ . “Y” is the number of photo-converted DCs
that accumulate in the dLN over time and are lost, either by death or egress, with the rate δY . (B) Fits of the model to data, showing the observed and best-fit
numbers of photo-converted DCs in draining lymph nodes for saline treatment (left-hand panel) and for alum/LPS treatment (right-hand panel).
the Kaede mouse system to identify the cells that leave a site of
immunization in the skin and then migrate to dLN. In contrast to
previous studies that suggest the migratory population is dermal
resident (23–25), we have identified that the cells recruited to
the site of challenge constitute the majority of the migratory
population. The precise nature of Kaede and the spatiotemporal
control we can exert when optically highlighting cells using
this method allows for a more in-depth analysis of migratory
behavior. This has allowed us to further study the origin of
migratory cells which the aforementioned studies were unable
to do. This likely explains why we have been able to identify
migratory cells as recruited rather than tissue resident.
Havingmeasured the kinetics of entry and egress of cells in the
skin, we investigated the phenotype of the migratory population.
Previous studies have identified that the skin is home to multiple
DC subsets. These populations are often split based on their
expression of CD103, CD11b, and CD207 (26, 27). However,
CD103 and CD11b double positive DCs have not previously
been identified in the skin, with the currently described subsets
expressing one marker or the other. Double positive DC were
previously thought only to reside in the intestine and associated
mesenteric LNs. As such we report the finding of migratory
CD103+CD11b+ DCs in the skin dLN as novel. In addition to
being a novel finding, we also make the intriguing observation
that this DC population constitutes themajority of themigratory,
antigen presenting DCs in the dLN. However, it is unclear if this
population of DCs has a preferential ability to acquire, process
and present antigen, or if CD103 is upregulated in response to
antigen acquisition or the environment of the lymph node, for
example through communication with antigen-specific T cells in
the lymph node in a manner similar to DC licensing (28).
In addition to DC subsets, we also identified multiple other
cell types that migrate, including T and B cells. While we have
not described these populations here, if they are undergoing
migration in response to an inflammatory stimulus, they could
participate in the initiation or regulation of adaptive immunity
in the dLN. The migration of B1 B cells is of particular note,
as while these cells have been described in relation to the skin
(29, 30), there have been no reports of their migration to the
dLN. We also identified that within the first 12 h post injection
there is an increase in the number of DCs and neutrophils at
the injection site in response to alum/LPS stimulation, with DC
numbers increasing 3-fold and neutrophil numbers increasing
20-fold. This increase is consistent with previous reports citing
an increase in neutrophils, DCs and monocytes after injection of
alum or MF59 (31).
By fitting and comparing a variety of mathematical models to
the data, we were able to generate a unified, quantitative view of
DC dynamics in both steady state and following inflammatory
stimuli. Turnover (loss) of DC in lymphoid and non-lymphoid
tissues has been studied by measuring the incorporation of labels
such as BrdU into the DNA of dividing cells (32–34). However,
the interpretation of labeling kinetics is heavily dependent on
assumptions regarding the relative contributions of influx and
local proliferation, cell-cell variation in residence times, and to
what extent any cells flowing into the tissue or LN are labeled
(35). (To illustrate, Ruedl et al. estimated LN residence time as the
time to plateau in BrdU labeling (32). If all labeled DC in the LN
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FIGURE 7 | Parameter estimates for the best fitting model in which µalum = µ0 + αte
−mt and µsaline = µ0. (A) the parameter estimates calculated from the
mathematical model are shown. (B) The number of migratory cells identified in the draining lymph node at various times with (C) a schematic of the migration pattern
observed over a 72 h period. (D) By combining the data generated from the experimental and mathematic approaches, it is predicted that the cells entering the tissue
will follow the same rate of decay and the estimated kinetics of cell migration from the skin to the lymph node and antigen presentation are summarized.
derive from influx, and cells leave the LN or die with first-order
kinetics, as has been observed for T cells (36) it can be shown that
the time to achieve a proportion f of LN cells labeled is log(1/f)T
where T is themean residence time. So, for example, 95% labeling
is only reached after approximately 3T). Estimates of residence
times in these studies were therefore approximate.
Relatively little is known regarding the turnover of DC in skin.
Ruedl et al. saw a slow accumulation of BrdU-labeled DC in skin
at steady state. From their BrdU kinetics (32), we estimate that
the mean residence time of DC in skin is at least 30d if all BrdU
labeled cells come from immigrants, and longer if there is any
in situ proliferation. In our model we assume no proliferation
within the skin (37), and that all egressing cells appear later in the
dLN. This model yields an estimated mean skin residence time
of 5.5d, though with some uncertainty (95% CI: 2–28d), which
is shorter than the rough estimate obtained from Ruedl et al. but
consistent at its upper bound (32).
Ruedl et al. found similarly slow accumulation of BrdU-
labeled skin-derived DC in the draining LN, from which they
inferred that residence times in dLN were long (32). However,
Kamath et al. pointed out that the similarity of the kinetics of
BrdU-labeled DC in skin and the dLN imply that turnover of DC
in the LN is relatively fast and that their numbers closely reflect
the flow of immigrants (33). We confirm the latter interpretation
by directly estimating LN residence times of only a few hours at
steady state. We do not distinguish egress and death within the
LN; however previous studies using the Kaede system found very
few labeled cells in other LN, supporting the conclusion that the
short residence time of DC in LN is due to cell death and not
egress (38).
Previous studies have reported that skin-derived DCs are first
detected 3–8 h after egress from skin (38–42). However, these
assays will tend to overestimate transit times because they neglect
residual residence times in skin, and in most cases detection of
signal is possible only after accumulation of substantial number
of DCs in the dLN. Using a dynamical model accounts for these
factors, and from it we estimate that DCs from skin spend
an average 2.6 h (0.06, 10.3) in the lymphatics before reaching
the dLN.
Various inflammatory stimuli have shown to transiently
enhance the migration of skin-derived DCs to the dLNs,
with a consensus that numbers of skin-derived DC reach a
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plateau by approximately 48 h and return to baseline level after
approximately a week (38, 40, 43). We observed a similar kinetic
of accumulation of DC in the dLNs following administration of
Alum/LPS and show that this kinetic is driven by a transient
increase in recruitment to skin and a rate of migration from
skin to dLN which peaks around a day post-challenge at
approximately 10-fold higher than the basal migration rate.
This increase is remarkably consistent with an estimate from
a previous study which used a semi-empirical approach to
quantify trafficking of fluorescently labeled skin-derived DCs to
dLNs, under inflammatory settings (38). Finally, our analysis
shows that the skin-derived DCs persist longer in dLNs upon
Alum/LPS administration as compared to control groups.
This observation opens up new avenues for improving the
effectiveness of DC-based vaccinations, by optimizing adjuvant
concentrations for sustained migration and longer retention
of DCs in dLNs.
In summary, using a combination of experiments and
dynamic modeling we have mapped and quantified the processes
underlying the kinetics of DC accumulation and loss in the
dLN in the first few days of an inflammatory response. We
find that, during the inflammatory response against alum/LPS,
the majority of the DC trafficking to the dLN are newly
recruited to the skin as a result of an inflammatory challenge.
Alum/LPS is a homolog of the alum based vaccine AS04,
and thus understanding where and when to target cells for
this vaccine strategy could prove fundamental in improving
It’s use. The migratory population comprises diverse subsets
of cells, and we show for the first time that these include a
population of antigen-presenting CD103+CD11b+ DCs and B1
B cells. Our analyses can guide future efforts to ensure that
the correct cells are targeted at the correct time and location
to maximize efficiency and efficacy when designing therapeutics
and vaccines.
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